[Individualized precision medicine]

Area of Science:

• Genomics and Molecular Biology
• Oncology
• Pharmacogenomics

Context:

• Personalized medicine has significantly advanced disease diagnosis and treatment paradigms.
• Molecular testing, particularly next-generation sequencing (NGS), is a cornerstone of personalized medicine.
• NGS analyzes tissue and liquid samples for diagnostic, prognostic, and predictive biomarker determination.

Purpose:

• To highlight the revolutionary impact of personalized medicine and molecular testing.
• To explain the role of next-generation sequencing in identifying biomarkers.
• To discuss the application of targeted therapies and resistance prediction.

Summary:

• Next-generation sequencing (NGS) enables precise molecular profiling of patient samples.
• Biomarker identification via NGS supports diagnostic, prognostic, and predictive applications.
• NGS facilitates targeted therapies and informs treatment decisions, including avoiding ineffective treatments due to resistance.

Impact:

• Advances in personalized medicine are transforming patient care and treatment strategies.
• Molecular testing improves treatment efficacy through targeted therapies.
• New molecular imaging techniques enhance understanding of tumor progression and targeted treatment development.